1.Concentrated Disinfectant Supply of Regional Medical Appliances and Its Cost Estimation
Weibei WU ; Shiqing HUANG ; Shijin FENG ; Ya LI
Chinese Journal of Nosocomiology 2006;0(02):-
OBJECTIVE To estimate the cost of concentrated disinfectant supply of medical appliances,so as to provide the primary basis for improving the concentrated disinfectant supply model,along with regional integration.METHODS Using contrasting methodologies,the cost level before and after the concentrated disinfectant supply with regional integration was compared,and the individual cost and total cost were analyzed.RESULTS Material and human resource cost was the core of total cost.Concentration management of regional medical appliances disinfection supply could significantly reduce costs.CONCLUSIONS Integrated management of concentrated disinfectant supply could reduce cost and economize expenses.Actually,this model is worth promoting.
2.Investigation on the antifungal activity of pyranium derivatives N2
Zhongyu DENG ; Shijin GUO ; Yifan GUO ; Juncheng FENG ; Quanzhen LV ; Lijuan QIU
Journal of Pharmaceutical Practice 2023;41(10):610-615
Objective To study the antifungal activity of N2 derivatives. Methods The anti-fungal activity of N2 compounds was investigated by micro-liquid dilution. Then the activity of N2 compounds on hyphal and biofilm formation was investigated. Results N2 compounds had significant antifungal activity against Candida albicans. It also expressed actively inhibitory effect on hyphal and biofilm formation. The mechanism of its fungicidal function was to damage the structure of candida albicans’ cell membrane and cell wall. Conclusion The results showed that N2 had obvious antifungal activity against Candida albicans., which provided a new idea for the development of antifungal drugs and the solution of antifungal drugs resistance.
3.Research progress on drug combination therapy against Candida albicans
Zhongyu DENG ; Shijin GUO ; Yifan GUO ; Juncheng FENG ; Quanzhen LYU ; Lijuan QIU
Journal of Pharmaceutical Practice 2023;41(6):352-357
Candida albicans is one of the most common species of Candida, which is an important cause of invasive candidiasis in clinic. Due to the frequently use of classical antifungal agents, there are amounts of drug resistant C. albicans being isolated, causing the significantly decreasing of the efficacy of some antifungal agents in clinical treatment. Besides, the use of some compounds in clinic has been limited because of their toxicities. In such a context, drug combination therapy shows great potential on antifungal because of the synergy of different drugs or therapeutic methods that could bring, which could improve the weaknesses of single drug.